FOENIX-CCA2: A phase II, open-label, multicenter study of futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 gene fusions or other rearrangements
Authors
Goyal, L.Meric-Bernstam, F.
Hollebecque, A.
Valle, Juan W
Morizane, C.
Karasic, T. B.
Furuse, J.
He, Y. H.
Soni, N.
Benhadji, K. A.
Bridgewater, J. A.
Affiliation
Massachusetts General Hospital, Boston, MAIssue Date
2020